JNJ

228.27

-0.51%↓

UNH

369.83

+0.22%↑

TMO

470.55

-1.31%↓

ISRG

459.32

+0.8%↑

ABT

90.03

-0.54%↓

JNJ

228.27

-0.51%↓

UNH

369.83

+0.22%↑

TMO

470.55

-1.31%↓

ISRG

459.32

+0.8%↑

ABT

90.03

-0.54%↓

JNJ

228.27

-0.51%↓

UNH

369.83

+0.22%↑

TMO

470.55

-1.31%↓

ISRG

459.32

+0.8%↑

ABT

90.03

-0.54%↓

JNJ

228.27

-0.51%↓

UNH

369.83

+0.22%↑

TMO

470.55

-1.31%↓

ISRG

459.32

+0.8%↑

ABT

90.03

-0.54%↓

JNJ

228.27

-0.51%↓

UNH

369.83

+0.22%↑

TMO

470.55

-1.31%↓

ISRG

459.32

+0.8%↑

ABT

90.03

-0.54%↓

Search

Integra LifeSciences Holdings Corp

Ouvert

SecteurSoins de santé

10.87 4.02

Résumé

Variation du prix de l'action

24h

Actuel

Min

10.14

Max

10.8

Chiffres clés

By Trading Economics

Revenu

3.7M

-1.7M

Ventes

33M

435M

Marge bénéficiaire

-0.392

Employés

4,427

EBITDA

12M

66M

Recommandations

By TipRanks

Recommandations

Vente

Prévisions sur 12 Mois

+4.36% upside

Dividendes

By Dow Jones

Prochains Résultats

5 mai 2026

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

-83M

833M

Ouverture précédente

6.85

Clôture précédente

10.87

Sentiment de l'Actualité

By Acuity

50%

50%

186 / 347 Classement par Healthcare

Score Technique

By Trading Central

Confiance

Strong Bearish Evidence

Integra LifeSciences Holdings Corp Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

30 avr. 2026, 23:08 UTC

Résultats

Australia's ANZ Warns of Coming Iran Impacts as First-Half Profit Rises -- Update

30 avr. 2026, 23:07 UTC

Résultats

Australia's Warns of Coming Iran Impacts as First-Half Profit Rises -- Update

30 avr. 2026, 22:20 UTC

Résultats

Australia's ANZ Raises 1st Half Profit 9%, Warns of Coming Iran Impacts

30 avr. 2026, 23:48 UTC

Market Talk

Nikkei May Rise After Gains on Wall Street -- Market Talk

30 avr. 2026, 23:47 UTC

Market Talk

Global Equities Roundup: Market Talk

30 avr. 2026, 23:47 UTC

Market Talk

Coles's Earnings Views Likely to Edge Down Despite Positives -- Market Talk

30 avr. 2026, 23:27 UTC

Market Talk

Liontown Lithium Recovery Expected to Improve -- Market Talk

30 avr. 2026, 23:22 UTC

Résultats

Apple's Incoming CEO John Ternus Makes Appearance as Company Bests Expectations -- Update

30 avr. 2026, 23:20 UTC

Market Talk

Wildcat Resources Stands Out Among Lithium Developers -- Market Talk

30 avr. 2026, 22:52 UTC

Résultats

Australia's ANZ Warns of Coming Iran Impacts as First-Half Profit Rises -- Update

30 avr. 2026, 22:33 UTC

Résultats

Zhejiang Expressway: Impairment Loss Weighed on Net >0576.HK

30 avr. 2026, 22:32 UTC

Résultats

Zhejiang Expressway 1Q Net CNY1.31B Vs. Net CNY1.48B >0576.HK

30 avr. 2026, 22:32 UTC

Résultats

Zhejiang Expressway 1Q Rev CNY5.32B Vs. CNY4.36B >0576.HK

30 avr. 2026, 22:24 UTC

Acquisitions, Fusions, Rachats

Mineral Resources: Also Reflects Time Needed to Implement Corporate Restructure For JV

30 avr. 2026, 22:23 UTC

Acquisitions, Fusions, Rachats

Mineral Resources: Revised Timetable Reflects Time Needed to Get Regulatory Approvals

30 avr. 2026, 22:23 UTC

Acquisitions, Fusions, Rachats

Mineral Resources: Now Expects Deal to Complete in 1H FY2027

30 avr. 2026, 22:23 UTC

Acquisitions, Fusions, Rachats

Mineral Resources: Executes Key Formal Agreements With Posco on Stake Sale

30 avr. 2026, 22:11 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

30 avr. 2026, 22:11 UTC

Market Talk

Global Equities Roundup: Market Talk

30 avr. 2026, 22:11 UTC

Market Talk

Apple Says Demand for Lower-Cost Laptop is Off the Charts -- Market Talk

30 avr. 2026, 22:05 UTC

Résultats

Australia's ANZ Raises 1H Profit 9%, Warns of Coming Iran Impacts

30 avr. 2026, 21:57 UTC

Résultats

ANZ CEO: Increase in Collective Provisions Reflects Risk>ANZ.AU

30 avr. 2026, 21:56 UTC

Résultats

ANZ CEO: Minimal Impact on ANZ's Credit, Capital, Liquidity>ANZ.AU

30 avr. 2026, 21:56 UTC

Résultats

ANZ CEO: No Material Increase in New Cases of Household Hardship>ANZ.AU

30 avr. 2026, 21:55 UTC

Résultats

ANZ CEO: Households Entered Crisis With Generally Strong Balance Sheets>ANZ.AU

30 avr. 2026, 21:54 UTC

Résultats

ANZ CEO: No Material Change in Overall Corporate Borrowing Behavior >ANZ.AU

30 avr. 2026, 21:54 UTC

Résultats

ANZ CEO: Corporate Customers Have Been Building Capital, Liquidity Against Shocks>ANZ.AU

30 avr. 2026, 21:53 UTC

Résultats

ANZ CEO: Much of Iran Conflict's Potential Impact Remains Ahead>ANZ.AU

30 avr. 2026, 21:49 UTC

Résultats

ANZ Group 1H Total Operating Income A$11.20B Vs. A$10.995B>ANZ.AU

30 avr. 2026, 21:49 UTC

Résultats

ANZ Group 1H Customer Deposits A$770.7B Vs. A$756.6B>ANZ.AU

Comparaison

Variation de prix

Integra LifeSciences Holdings Corp prévision

Objectif de Prix

By TipRanks

4.36% hausse

Prévisions sur 12 Mois

Moyen 11 USD  4.36%

Haut 12 USD

Bas 9 USD

Basé sur 6 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Vente

6 ratings

0

Achat

4

Maintien

2

Vente

Score Technique

By Trading Central

12.75 / 16.41Support & Résistance

Court Terme

Strong Bearish Evidence

Moyen Terme

Strong Bearish Evidence

Long Terme

Weak Bearish Evidence

Sentiment

By Acuity

186 / 347Classement par Soins de santé

Sentiment de l'Actualité

Neutral

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Inférieur à la moyenne

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Integra LifeSciences Holdings Corp

Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical products, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as after-market services. It also sells instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices. In addition, the company provides regenerative technology products for the treatment of acute wounds; and surgical tissue repair products for hernia, tendon, peripheral nerve repair and protection. Further, it offers skin and wound repair, plastics and surgical reconstruction products, bone grafts, and nerve and tendon repair products. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.
help-icon Live chat